Език: EN EN
← Назад към резултатите
Набира участници NCT07541937

Doppler Flow in Tubal Ectopic Pregnancy in Diagnosis as a Predictor of Treatment Success - Conservative and MTX Treatment

Заболявания: Ectopic Pregnancy

Спонсор: Meir Medical Center

Налично на: БГ
Обобщение
The study "Doppler Flow in Tubal Ectopic Pregnancy as a Predictor of Treatment Success: Conservative and MTX Therapy" aims to evaluate the role of Doppler ultrasound parameters (RI, PI, and PSV) in predicting treatment success for tubal ectopic pregnancies. Ectopic pregnancies, affecting \~2% of all pregnancies (98% in fallopian tubes), pose significant risks, including rupture and maternal mortality. Diagnosis is typically achieved via transvaginal ultrasound, with Doppler imaging enhancing accuracy by detecting characteristic vascular patterns. Management options include conservative monitoring, methotrexate (MTX) therapy, or surgery, based on clinical stability, β-hCG levels, and ultrasound findings. While β-hCG levels are a known predictor of MTX treatment failure, there is no consensus on an optimal threshold. Prior research suggests increased vascularization on Doppler ultrasound may correlate with higher MTX success rates. This prospective study will involve 60 women aged 18-45 with stable, unruptured tubal ectopic pregnancies. It will assess Doppler parameters and other clinical factors as predictors of treatment success. Findings aim to address gaps in the literature and improve management strategies for tubal ectopic pregnancies.
Описание
Study Objectives: * Primary Objectives: Assess the predictive value of Doppler flow parameters (RI, PI, and PSV) at diagnosis for conservative management success or MTX therapy success in tubal ectopic pregnancies. * Secondary Objectives: Evaluate the predictive value of additional parameters such as gestational age, yolk sac presence, embryonic pole presence, CRL, fetal heartbeat, abdominal fluid, pain severity, vaginal bleeding, and β-hCG levels. Study Design: * Prospective study including women diagnosed with tubal ectopic pregnancy. * Participants must be hemodynamically stable with no suspicion of tubal rupture. * Doppler parameters and clinical/laboratory data will be recorded at diagnosis, followed by treatment based on departmental protocols. Population: * Women aged 18-45 diagnosed with tubal ectopic pregnancy. * Inclusion and exclusion criteria based on stability, location of ectopic pregnancy, and lack of rupture suspicion. Sample Size: Based on previous studies, 60 participants (to allow for 10% loss to follow-up) will provide 80% statistical power to evaluate Doppler parameters as predictors of treatment success. This study aims to address the gap in the literature regarding the role of Doppler vascularization in predicting treatment outcomes for tubal ectopic pregnancy.
Кой може да участва
Inclusion criteria: * Tubal ectopic pregnancy * Hemodynamically stable, with no suspicion of rupture, * Eligible for MTX or conservative therapy. Exclusion criteria: * Intrauterine pregnancy * Hemodynamic instability * Suspected tubal rupture * Other ectopic pregnancy: CSP, Ovarian, heterotopic pregnancy
Места на провеждане 1
Израел (1)
Meir Medical Center
Kfar Saba , Israel
Технически детайли
Статус
Набира участници
Вид изследване
OBSERVATIONAL
Пол
Само жени
Минимална възраст
18 Years
Максимална възраст
45 Years
Здрави доброволци
Не
Начална дата
01.06.2024
Крайна дата
01.06.2027
Регистрационен номер
NCT07541937
Източник
clinicaltrials.gov
Запитване за медицински туризъм

Информацията е извлечена автоматично от ClinicalTrials.gov. Консултирайте се с вашия лекар преди да предприемете действия.